Total Funding
25
37
Total FundingDebt Financing raised
Growth Score
-30 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
129877
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.
- Bradford Sippy: CEO and FounderPast Role: Tremeau Pharmaceuticals, Founder, Chairman & CEO
About the Company
Lennham Pharmaceuticals is a pharmaceutical company that helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry. It focuses on the application of deuterium chemistry to well-characterized compounds that have enabled it to develop a pipeline of products such as deuterium-enriched forms of psilocybin, and
caffeine.
